MedPath

nani formulation (Sharbat-e-Toot Siyah) in Warm-e-Halaq Muzmin(Chronic Pharyngitis) patients

Phase 2
Not yet recruiting
Conditions
Health Condition 1: J312- Chronic pharyngitis
Registration Number
CTRI/2024/07/069725
Lead Sponsor
Jamia Hamdard
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Diagnosed patients of chronic pharyngitis (Pharyngitis more than 3 months) presenting with all OR more than three of the following signs and symptoms

Sore throat

Dysphagia

Foreign body sensation

Burning sensation

Cough

Hoarseness of voice

Pharyngeal itching

Posterior pharyngeal wall hypertrophy

oedema

redness

Exclusion Criteria

1)Age below 18 and above 65 years

2)Pregnant and lactating women

3)Congenital malformations of oropharynx

4)Diabetes mellitus

5)Oral candidiasis

6)Unwilling to participate in the study

7)Epiglottitis, Thyroiditis

8)Retropharyngeal abscess/peritonsillar abscess

9)Dental Sepsis

10)Carcinoma of throat

11)History of previous use of corrosives

12)Pts with Chronic liver, kidney or heart disease

13)Pts suffering from psychiatric disorders

14)History of seizures, severe HTN

15)Pts having carcinoma and terminal illness

16)Pts taking antibiotics for the current illness for last one week

17)Pts on regular steroid inhalers: MDI (Metered Dose Inhalers)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Improvement in Subjective Parameters i.e. symptoms to be assessed on Visual Analogue Scale (0 to 100 mm) <br/ ><br>Sore throat <br/ ><br>Dysphagia <br/ ><br>Foreign body sensation <br/ ><br>Burning sensation <br/ ><br>Cough <br/ ><br>Hoarseness of voice <br/ ><br>Pharyngeal itching <br/ ><br>2. Improvement in Objective Parameters i.e. PHARYNGOSCOPY will be used to analyse the signs of Chronic Pharyngitis [Grading on Likert Scale (4 point)] on following Pharyngeal Signs <br/ ><br>Hypertrophy <br/ ><br>Oedema <br/ ><br>Redness <br/ ><br> <br/ ><br>Timepoint: Baseline and 6 weeks
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life (QoL)Timepoint: 0 & 6 weeks
© Copyright 2025. All Rights Reserved by MedPath